1. Hajia M, Rahbar M, Fallah F, Safadel N. Detection of Bordetella pertussis in Infants Suspected to have Whooping Cough. Open Respir Med J 2012; 6: 34–6.
2. Melvin JA, Scheller EV, Miller JF, Cotter PA. Bordetella pertussis pathogenesis: current and future challenges. Nat Rev Microbiol 2014;12(4):274-88.
3. Mattoo S, Cherry JD. Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clinical Microbiology Reviews 2005;18(2):326-82.
4. Tan T, Trindade E, Skowronski D. Epidemiology of pertussis. Pediatr Infect Dis J 2005;24(5 Suppl):S10-8.
5. Centers for Disease Control and Prevention (CDC), Morbidity and Mortality Weekly Report (MMWR). Vaccine preventable deaths and the Global Immunization.Vision and Strategy, 2006-2015. Available from: https://www.cdc.gov/mmwr/preview/mmwrhtml/mm5518a4.htm
6. Asgarian-Omran H, Amirzargar AA, Arjmand M, Eshraghian M, Nikbin B, Eshraghi S, et al. Expression, purification and characterization of three overlapping immunodominant recombinant fragments from bordetella pertussis filamentous hemagglutinin. Avicenna Journal of Medical Biotechnology 2013;5(1):20-8.
7. Esteghamati A, Mansoor Ghanati R, Dosti F. Guideline for surveillance of pertussis. 2th ed. Tehran: Ministry of Health and Medical Education; 2009. Persian
8. Saffar MJ, Ajami A, Khalilian AR, Qaheri A, Saffar H. Pertussis seroimmunity among mother-infant pairs and infant immune response to pertussis vaccination. Indian Pediatr 2007;44(12):916-8.
9. Saffar MJ, Khalilian AR, Rafee AR, Parsaei MR, Imanikhani S, Shojaei J, et al. Bordetella pertussis IgG and IgA antibodies seroprevalence among 1-35 y-old population: the role of subclinical pertussis infection. Indian J Pediatr 2012;79(3):353-7.
10. Committee on Infectious Diseases American Academy of Pediatrics. In: Pickering LK, Baker CJ,
Kimberlin DW, Long SS, editors. Red Book: 2009 Report of the Committee on Infectious Diseases. 28th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2009.
11. Plotkin SA, Orenstein WA, Offit PA.Vaccines. 6th ed. Philadelphia, Pa: Elsevier/Saunders; 2013.
12. Akhavizadegan MA. Evaluating and comparing the effect of the domestic triple vaccine for Diphtheria, Tetanus and Pertussis (D.T.P) in children under one year old in Iran [dissertation]. Tehran: Tehran University of Medical Science; 1996.
13. Zareei S, Jedi Tehrani M, Akhoundi M, Zarnani AH, Zeraati HA, Bonakdar S, et al. Short Term Reactogenicity of Cellular Dtp Vaccine in 4-6 Year Old Children in Tehran, Iran. Payesh 2007; 6(3): 273-83. Persian
14. Thierry-Carstensen B, Dalby T, Stevner MA, Robbins JB, Schneerson R, Trollfors B. Experience with monocomponent acellular pertussis combination vaccines for infants, children, adolescents and adults--a review of safety, immunogenicity, efficacy and effectiveness studies and 15 years of field experience. Vaccine 2013;31(45):5178-91.
15. Forsyth KD, Wirsing von Konig CH, Tan T, Caro J, Plotkin S. Prevention of pertussis: recommendations derived from the second Global Pertussis Initiative roundtable meeting. Vaccine 2007;25(14):2634-42.
16. Barreto L, Guasparini R, Meekison W, Noya F, Young L, Mills E. Humoral immunity 5 years after booster immunization with an adolescent and adult formulation combined tetanus, diphtheria, and 5-component acellular pertussis vaccine. Vaccine 2007;25(48):8172-9.
17. Le T, Cherry JD, Chang SJ, Knoll MD, Lee ML, Barenkamp S, et al. Immune responses and antibody decay after immunization of adolescents and adults with an acellular pertussis vaccine: the APERT Study. J Infect Dis 2004;190(3):535-44.
18. Munoz F, Englund J. Infant pertussis: is cocooning the answer? Clin Infect Dis 2011;53(9):893-6.
19. Westra TA, de Vries R, Tamminga JJ, Sauboin CJ, Postma MJ. Cost-effectiveness analysis of various pertussis vaccination strategies primarily aimed at protecting infants in the Netherlands. Clin Ther 2010;32(8):1479-95.
20. Belloni C, De Silvestri A, Tinelli C, Avanzini MA, Marconi M, Strano F, et al. Immunogenicity of a three-component acellular pertussis vaccine administered at birth. Pediatrics 2003;111(5 Pt 1):1042-5.
21. Halasa NB, O'Shea A, Shi JR, LaFleur BJ, Edwards KM. Poor immune responses to a birth dose of diphtheria, tetanus, and acellular pertussis vaccine. J Pediatr 2008;153(3):327-32.
22. Knuf M, Schmitt HJ, Wolter J, Schuerman L, Jacquet JM, Kieninger D, et al. Neonatal vaccination with an acellular pertussis vaccine accelerates the acquisition of pertussis antibodies in infants. J Pediatr 2008;152(5):655-60.
23. Wood N, McIntyre P, Marshall H, Roberton D. Acellular pertussis vaccine at birth and one month induces antibody responses by two months of age. Pediatr Infect Dis J 2010;29(3):209-15.
)